Cargando…
A re-appraisal of mesenchymal-epithelial transition (MET) in endometrial epithelial remodeling
Mesenchymal-epithelial transition (MET) is a mechanism of endometrial epithelial regeneration. It is also implicated in adenocarcinoma and endometriosis. Little is known about this process in normal uterine physiology. Previously, using pregnancy and menses-like mouse models, MET occurred only as an...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889438/ https://www.ncbi.nlm.nih.gov/pubmed/36401092 http://dx.doi.org/10.1007/s00441-022-03711-z |
_version_ | 1784880730167312384 |
---|---|
author | Spooner-Harris, Madelyn Kerns, Karl Zigo, Michal Sutovsky, Peter Balboula, Ahmed Patterson, Amanda L. |
author_facet | Spooner-Harris, Madelyn Kerns, Karl Zigo, Michal Sutovsky, Peter Balboula, Ahmed Patterson, Amanda L. |
author_sort | Spooner-Harris, Madelyn |
collection | PubMed |
description | Mesenchymal-epithelial transition (MET) is a mechanism of endometrial epithelial regeneration. It is also implicated in adenocarcinoma and endometriosis. Little is known about this process in normal uterine physiology. Previously, using pregnancy and menses-like mouse models, MET occurred only as an epithelial damage/repair mechanism. Here, we hypothesized that MET also occurs in other physiological endometrial remodeling events, outside of damage/repair, such as during the estrous cycle and adenogenesis (gland development). To investigate this, Amhr2-Cre-YFP/GFP mesenchyme-specific reporter mice were used to track the fate of mesenchymal-derived (MD) cells. Using EpCAM (epithelial marker), EpCAM(+)YFP(+) MD-epithelial cells were identified in all stages of the estrous cycle except diestrus, in both postpartum and virgin mice. EpCAM(+)YFP(+) MD-epithelial cells comprised up to 80% of the epithelia during estrogen-dominant proestrus and significantly declined to indistinguishable from control uteri in diestrus, suggesting MET is hormonally regulated. MD-epithelial cells were also identified during postnatal epithelial remodeling. MET occurred immediately after birth at postnatal day (P) 0.5 with EpCAM(+)GFP(+) cells ranging from negligible (0.21%) to 82% of the epithelia. EpCAM(+)GFP(+) MD-epithelial cells declined during initiation of adenogenesis (P8, avg. 1.75%) and then increased during gland morphogenesis (P14, avg. 10%). MD-epithelial cells expressed markers in common with non-MD-epithelial cells (e.g., EpCAM, FOXA2, ESR1, PGR). However, MD-epithelial cells were differentially regulated postnatally and in adults, suggesting a functional distinction in the two populations. We conclude that MET occurs not only as an epithelial damage/repair mechanism but also during other epithelial remodeling events, which to our knowledge has not been demonstrated in other tissues. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00441-022-03711-z. |
format | Online Article Text |
id | pubmed-9889438 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-98894382023-02-02 A re-appraisal of mesenchymal-epithelial transition (MET) in endometrial epithelial remodeling Spooner-Harris, Madelyn Kerns, Karl Zigo, Michal Sutovsky, Peter Balboula, Ahmed Patterson, Amanda L. Cell Tissue Res Regular Article Mesenchymal-epithelial transition (MET) is a mechanism of endometrial epithelial regeneration. It is also implicated in adenocarcinoma and endometriosis. Little is known about this process in normal uterine physiology. Previously, using pregnancy and menses-like mouse models, MET occurred only as an epithelial damage/repair mechanism. Here, we hypothesized that MET also occurs in other physiological endometrial remodeling events, outside of damage/repair, such as during the estrous cycle and adenogenesis (gland development). To investigate this, Amhr2-Cre-YFP/GFP mesenchyme-specific reporter mice were used to track the fate of mesenchymal-derived (MD) cells. Using EpCAM (epithelial marker), EpCAM(+)YFP(+) MD-epithelial cells were identified in all stages of the estrous cycle except diestrus, in both postpartum and virgin mice. EpCAM(+)YFP(+) MD-epithelial cells comprised up to 80% of the epithelia during estrogen-dominant proestrus and significantly declined to indistinguishable from control uteri in diestrus, suggesting MET is hormonally regulated. MD-epithelial cells were also identified during postnatal epithelial remodeling. MET occurred immediately after birth at postnatal day (P) 0.5 with EpCAM(+)GFP(+) cells ranging from negligible (0.21%) to 82% of the epithelia. EpCAM(+)GFP(+) MD-epithelial cells declined during initiation of adenogenesis (P8, avg. 1.75%) and then increased during gland morphogenesis (P14, avg. 10%). MD-epithelial cells expressed markers in common with non-MD-epithelial cells (e.g., EpCAM, FOXA2, ESR1, PGR). However, MD-epithelial cells were differentially regulated postnatally and in adults, suggesting a functional distinction in the two populations. We conclude that MET occurs not only as an epithelial damage/repair mechanism but also during other epithelial remodeling events, which to our knowledge has not been demonstrated in other tissues. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00441-022-03711-z. Springer Berlin Heidelberg 2022-11-19 2023 /pmc/articles/PMC9889438/ /pubmed/36401092 http://dx.doi.org/10.1007/s00441-022-03711-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Regular Article Spooner-Harris, Madelyn Kerns, Karl Zigo, Michal Sutovsky, Peter Balboula, Ahmed Patterson, Amanda L. A re-appraisal of mesenchymal-epithelial transition (MET) in endometrial epithelial remodeling |
title | A re-appraisal of mesenchymal-epithelial transition (MET) in endometrial epithelial remodeling |
title_full | A re-appraisal of mesenchymal-epithelial transition (MET) in endometrial epithelial remodeling |
title_fullStr | A re-appraisal of mesenchymal-epithelial transition (MET) in endometrial epithelial remodeling |
title_full_unstemmed | A re-appraisal of mesenchymal-epithelial transition (MET) in endometrial epithelial remodeling |
title_short | A re-appraisal of mesenchymal-epithelial transition (MET) in endometrial epithelial remodeling |
title_sort | re-appraisal of mesenchymal-epithelial transition (met) in endometrial epithelial remodeling |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889438/ https://www.ncbi.nlm.nih.gov/pubmed/36401092 http://dx.doi.org/10.1007/s00441-022-03711-z |
work_keys_str_mv | AT spoonerharrismadelyn areappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling AT kernskarl areappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling AT zigomichal areappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling AT sutovskypeter areappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling AT balboulaahmed areappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling AT pattersonamandal areappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling AT spoonerharrismadelyn reappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling AT kernskarl reappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling AT zigomichal reappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling AT sutovskypeter reappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling AT balboulaahmed reappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling AT pattersonamandal reappraisalofmesenchymalepithelialtransitionmetinendometrialepithelialremodeling |